Trial Profile
COMPARATIVE STUDY OF OUTCOME OF PROLIFERATIVE LUPUS NEPHRITIS WITH NIH REGIMEN VERSUS TACROLIMUS AND MYCOPHENOLICACID COMBINATION AS INDUCTION THERAPY
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Mycophenolate sodium (Primary) ; Tacrolimus (Primary) ; Methylprednisolone; Prednisolone
- Indications Lupus nephritis
- Focus Adverse reactions; Therapeutic Use
- 13 Mar 2013 New trial record